MUNICH & CARLSBAD, Calif.--(BUSINESS WIRE)-- <\/p>\n
Definiens, a healthcare company that advances personalized medicine through image analysis and digital pathology solutions, today released tips for integrating data mining with image analysis. As pathologists, researchers and clinicians seek to advance personalized medicine through the development and prescription of targeted therapies, data generated through image analysis of digitized tissue sections is becoming essential to stratifying patients and providing personalized care. <\/p>\n
With the increasing prevalence and need for personalized medicine, the importance of tissue datafication through image analysis is becoming ever more present. While genomic data is highly valuable, it will be the correlation of genomics and tissue phenomics with patient outcomes that brings a level of accuracy to diagnosis, prognosis, and therapy that cant be met with genomic data alone, says Thomas Heydler, CEO of Definiens. <\/p>\n
Definiens five steps for researchers and clinicians to effectively utilize data mining with tissue image analysis include: <\/p>\n
For more information on Definiens, visit http:\/\/www.Definiens.com<\/a>. <\/p>\n About Definiens <\/p>\n Definiens is the leading provider of image analysis and data mining solutions for life science, tissue diagnostics, and clinical digital pathology. Definiens' technology provides detailed biomarker readouts from whole slide images and enables the correlation of this information with other key clinical or genomic data. Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and support better decisions in research, diagnostics and therapy. <\/p>\n Definiens vision is to open new fields of research, to contribute to development of personalized medicine, and to significantly improve the quality of patients' lives. Definiens is headquartered in Munich, Germany and has its North American headquarters in Carlsbad, CA. Further information is available at http:\/\/www.definiens.com<\/a>. <\/p>\n<\/p>\n <\/p>\n Read more:<\/p>\n Personalized Medicine Roadmap: Definiens Releases Five Steps to Utilize Data Mining with Image Analysis<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" MUNICH & CARLSBAD, Calif.--(BUSINESS WIRE)-- Definiens, a healthcare company that advances personalized medicine through image analysis and digital pathology solutions, today released tips for integrating data mining with image analysis. As pathologists, researchers and clinicians seek to advance personalized medicine through the development and prescription of targeted therapies, data generated through image analysis of digitized tissue sections is becoming essential to stratifying patients and providing personalized care. With the increasing prevalence and need for personalized medicine, the importance of tissue datafication through image analysis is becoming ever more present Continue reading